1. Home
  2. KYTX vs IDN Comparison

KYTX vs IDN Comparison

Compare KYTX & IDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KYTX
  • IDN
  • Stock Information
  • Founded
  • KYTX 2018
  • IDN 1994
  • Country
  • KYTX United States
  • IDN United States
  • Employees
  • KYTX N/A
  • IDN N/A
  • Industry
  • KYTX
  • IDN Computer Software: Prepackaged Software
  • Sector
  • KYTX
  • IDN Technology
  • Exchange
  • KYTX NYSE
  • IDN Nasdaq
  • Market Cap
  • KYTX 119.7M
  • IDN 101.6M
  • IPO Year
  • KYTX 2024
  • IDN 1999
  • Fundamental
  • Price
  • KYTX $4.33
  • IDN $5.14
  • Analyst Decision
  • KYTX Strong Buy
  • IDN Strong Buy
  • Analyst Count
  • KYTX 5
  • IDN 3
  • Target Price
  • KYTX $19.00
  • IDN $5.83
  • AVG Volume (30 Days)
  • KYTX 599.4K
  • IDN 257.8K
  • Earning Date
  • KYTX 08-11-2025
  • IDN 08-12-2025
  • Dividend Yield
  • KYTX N/A
  • IDN N/A
  • EPS Growth
  • KYTX N/A
  • IDN N/A
  • EPS
  • KYTX N/A
  • IDN N/A
  • Revenue
  • KYTX N/A
  • IDN $20,211,000.00
  • Revenue This Year
  • KYTX N/A
  • IDN $9.35
  • Revenue Next Year
  • KYTX N/A
  • IDN $13.05
  • P/E Ratio
  • KYTX N/A
  • IDN N/A
  • Revenue Growth
  • KYTX N/A
  • IDN 4.55
  • 52 Week Low
  • KYTX $1.78
  • IDN $1.92
  • 52 Week High
  • KYTX $10.08
  • IDN $6.49
  • Technical
  • Relative Strength Index (RSI)
  • KYTX 63.84
  • IDN 48.44
  • Support Level
  • KYTX $3.80
  • IDN $5.08
  • Resistance Level
  • KYTX $4.39
  • IDN $5.71
  • Average True Range (ATR)
  • KYTX 0.39
  • IDN 0.22
  • MACD
  • KYTX 0.05
  • IDN -0.04
  • Stochastic Oscillator
  • KYTX 93.78
  • IDN 14.93

About KYTX KYVERNA THERAPEUTICS INC

Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product, KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.

About IDN Intellicheck Inc.

Intellicheck Inc is a trusted industry leader in technology solutions that stop identity theft and fraud with real-time identification authentication and age verification. The group delivers on-demand digital and physical identity verification solutions for KYC, AML, fraud prevention, and age verification needs. The products of the company include solutions for preventing identity fraud across any industry delivered via smartphone, tablet, POS integration or other electronic devices.

Share on Social Networks: